Noor Shaker

Co-founder and CEO, GTN
When
16th-17th Nov 2020
Start Time 08:50 (GMT, UTC)
Where
Virtual Conference
The meeting will explore how AI, Data Science and informatics is transforming Pharma R&D. In particular, two summits will focus on drug discovery & pre-clinical development and biomarkers & clinical development.
AI for genomics, single-cell analysis and target validation, AI for predicting patient response, AI impacting clinical trials, AI for imaging, AI for cancer immunotherapy and neurodegenerative diseases, clinical informatics, data integration, management and storage, digital therapeutics, wearables and sensors.
Once again, the meeting is co-located with the 5th Medicinal Chemistry Summit. Both meetings take place online on 16 & 17 November 2020. A delegate pass gives you access to all the presentations at both events.
“Almost everyone was there. Speaking slots were not too short. Generous networking sessions. Co-location with other interesting conferences”
“Very good speakers and presentations Great networking sections with people in multidisciplinary fields”
“Great talks on real-world pragmatic application of AI”
Global Pharma R&D AI, Data Science & Informatics Summit (PRADI 2020) | |||
AI, Data Science & Informatics for Drug Discovery and Preclinical Development | AI, Data Science & Informatics for Biomarkers and Clinical Development | ||
Advances in AI – Algorithms, Machine Learning, Deep Learning & Quantum Computing | Data Curation, Integration & Management – Software Tools, Data Networks, Emerging Standards, Blockchain | AI for Predicting Response – Biomarker Discovery, New Predictive Models, Case Studies | Clinical Informatics – Natural Language Processing, Knowledge Discovery, Real World Evidence |
Emerging Applications of AI – Genomics, Single Cell Analysis, Target Identification, Target Validation | Advances in Knowledge Discovery – Natural Language Processing, Information and Knowledge Visualization | AI Impacting Clinical Trials – Patient Recruitment, Trial Design, Patient Monitoring, Case Studies | Clinical Data Integration & Management – EMRs, Interoperbility, Blockchain |
AI for Smart Chemistry – Medicinal Chemistry, ADME, Toxicology, Pharmacology | Data Analysis & Informatics – ‘Omics, Molecular Biology, Systems Biology | Applying AI to Imaging & Computer Vision – Phenotypic Drug Discovery, Biomarker Discovery, Digital Pathology | Digital & Evidence-Based Therapeutics – Discovery, Development, Clinical Trials, Regulation |
AI for Next-Generation Biologics – Antibodies, Gene & Immunotherapies | R&D Digitization & Automation – Software Tools, Lab Automation, IoT | AI for Cancer Immunotherapy Discovery & Development – Vaccines, Neoantigens, Biomarkers, Combinations | Clinical Data Collection Tools – IoT, Wearables, Sensors, Clinical Trials |
SVP of Data Science & AI, Valo Health
Director, Analytics & AI, GSK
Head, Early Development Informatics, Roche
Founder and CEO, Peptone
SVP Global Head, Artificial Intelligence and Machine Learning, GSK
Assistant Professor, University of Cambridge; Research Scientist, Google
Senior Biomedical Informatics Scientist, Biometrics and Information Sciences, AstraZeneca
Associate Director and Team Leader, AstraZeneca
Director, Health Informatics, AstraZeneca
Senior Data and Analytics Engineer, Early Science, AstraZeneca
Computational Chemist, GSK
Co-Founder and Lead ML Scientist, Dyno Therapeutics
CSO, Cognetivity
Biomedical Data Scientist, Data Science Institute, Imperial College London
Senior Machine Learning Scientist, European Bioinformatics Institute (EMBL-EBI)
Head, Machine Learning, Intellegens
Principal Data Scientist, Amgen
Senior Bioinformatics Data Scientist, FDA
Genetics Data Science Lead, C4X Discovery
CEO, Arctoris Ltd
Applications Specialist, CAS
Founder & CEO & CSO, Denovicon Therapeutics
Senior Director, Customs Solutions,CAS
Director, BD and Solutions Engineering, Mcule
Managing Director, CAS
Head, Data Science, Chemical Biology & Therapeutics, Novartis
Senior scientist, STANDIGM
CEO & Founder, LabGenius
Head, IT, Early Solutions Innovation Development, UCB
Head of Computational Biology, Milner Therapeutics Institute, University of Cambridge
COO, Metadvice
Co-founder and CEO, GTN
Chief Scientific Officer, Molomics
VP, Software and Applications, Seer
Chief Information and Privacy Officer, Luna PBC
Head, Discovery Informatics, e-therapeutics
Senior Vice President, Artificial Intelligence, Immuneering Corporation
CSO & SVP Clinical and Translational Sciences, BERG
Portfolio Lead, Scientific Informatics, Dassault Systèmes BIOVIA.
Deputy Chief Scientific Officer, Office of the Chief Scientific Officer, NHS England
Augmented Drug Design Platform Lead, AstraZeneca
Text Analytics Lead, IT Advanced Analytics, Merck KGaA
Executive Director and Head, IT, Bristol Myers Squibb
Head, Data and Knowledge Management, German Center for Diabetes Research
VP, Data Science, Benevolent AI
Professor, Bioinformatics and Computational Biology, UCL
Group Director, Personalized Healthcare (PHC) Data Science, Neuroscience Analytics, Roche
CSO, A2A Pharmaceuticals
Principal Data Scientist, Advanced Analytics, Sanofi
Principal Bioinformatics Scientist, Associate Director, Centre for Genomics Research, AstraZeneca
Computational Toxicology, Cheminformatics, GSK
Associate Director of Data Science, Novartis
Director, Artificial Intelligence, US Department of Veterans Affairs
Chief Scientific Officer, Machine Medicine Technologies
SVP of Data Science & AI, Valo Health
Director, Analytics & AI, GSK
Head, Early Development Informatics, Roche
Founder and CEO, Peptone
SVP Global Head, Artificial Intelligence and Machine Learning, GSK
Assistant Professor, University of Cambridge; Research Scientist, Google
Senior Biomedical Informatics Scientist, Biometrics and Information Sciences, AstraZeneca
Associate Director and Team Leader, AstraZeneca
Director, Health Informatics, AstraZeneca
Senior Data and Analytics Engineer, Early Science, AstraZeneca
Computational Chemist, GSK
Co-Founder and Lead ML Scientist, Dyno Therapeutics
CSO, Cognetivity
Biomedical Data Scientist, Data Science Institute, Imperial College London
Senior Machine Learning Scientist, European Bioinformatics Institute (EMBL-EBI)
Head, Machine Learning, Intellegens
Principal Data Scientist, Amgen
Senior Bioinformatics Data Scientist, FDA
Genetics Data Science Lead, C4X Discovery
CEO, Arctoris Ltd
Applications Specialist, CAS
Founder & CEO & CSO, Denovicon Therapeutics
Senior Director, Customs Solutions,CAS
Director, BD and Solutions Engineering, Mcule
Managing Director, CAS
Head, Data Science, Chemical Biology & Therapeutics, Novartis
Senior scientist, STANDIGM
CEO & Founder, LabGenius
Head, IT, Early Solutions Innovation Development, UCB
Head of Computational Biology, Milner Therapeutics Institute, University of Cambridge
COO, Metadvice
Co-founder and CEO, GTN
Chief Scientific Officer, Molomics
VP, Software and Applications, Seer
Chief Information and Privacy Officer, Luna PBC
Head, Discovery Informatics, e-therapeutics
Senior Vice President, Artificial Intelligence, Immuneering Corporation
CSO & SVP Clinical and Translational Sciences, BERG
Portfolio Lead, Scientific Informatics, Dassault Systèmes BIOVIA.
Deputy Chief Scientific Officer, Office of the Chief Scientific Officer, NHS England
Augmented Drug Design Platform Lead, AstraZeneca
Text Analytics Lead, IT Advanced Analytics, Merck KGaA
Executive Director and Head, IT, Bristol Myers Squibb
Head, Data and Knowledge Management, German Center for Diabetes Research
VP, Data Science, Benevolent AI
Professor, Bioinformatics and Computational Biology, UCL
Group Director, Personalized Healthcare (PHC) Data Science, Neuroscience Analytics, Roche
CSO, A2A Pharmaceuticals
Principal Data Scientist, Advanced Analytics, Sanofi
Principal Bioinformatics Scientist, Associate Director, Centre for Genomics Research, AstraZeneca
Computational Toxicology, Cheminformatics, GSK
Associate Director of Data Science, Novartis
Director, Artificial Intelligence, US Department of Veterans Affairs
Chief Scientific Officer, Machine Medicine Technologies
Option 1 – Please phone +44 (0) 1865 671957 ext. 207 and we will take your details over the phone
Option 2 – Please complete the form below to pay online
£199.00
For foreign organisation delegate ticket fee
FREE
This pass gives you limited access to the meeting. Check the details above.
£799.00
Fee for representatives of organisations offering services and/or business & technology solutions and also to business consultants.
Dassault Systèmes, the 3DEXPERIENCE Company, provides business and people with virtual universes to imagine sustainable innovations. Its world-leading solutions transform the way products are designed, produced, and supported. Dassault Systèmes’ collaborative solutions foster social innovation, expanding possibilities for the virtual world to improve the real world. The group brings value to over 250, 000 customers of all sizes, in all industries, in more than 140 countries. For more information, visit www.3ds.com
×Mcule operates chemical marketplaces for drug discovery where you can order more than 170 million small-molecule samples from a high-quality database and request custom synthesis. You can utilize our aggregated supplier catalogs (Mcule database), 100M+ novel, synthetically accessible molecules (ULTIMATE database), rapid custom synthesis offers via our reverse auction site (SynthAgora), and the synergies between these three chemical marketplaces in your projects. Mcule’s services combine cheminformatic capabilities with our automated compound management laboratory to ensure that you quickly receive the right compounds in the requested assay-ready format.
×CAS is a specialist in scientific information solutions.
We curate, connect, and analyze scientific information revealing unique insights that accelerate breakthroughs. Leading commercial, government and academic institutions worldwide rely on CAS to turn scientific information into competitive advantages through:
Eurofins Discovery supports drug discovery through the combined expertise of Cerep, DiscoverX, Panlabs, Villapharma, and Selcia Drug Discovery. We offer a broad portfolio including medicinal and synthetic chemistry, in vitro pharmacology products and services, cell-based phenotypic assays, ADME-Tox, in vivo drug safety and efficacy, custom proteins, and assay development services.
https://www.eurofinsdiscoveryservices.com/
×Selvita is an integrated service company providing multidisciplinary support in resolving the unique challenges of research within area of drug discovery, regulatory studies, as well as research and development.
The company was established in 2007 and currently employs over 500 professionals. Selvita is headquartered in Krakow, Poland, with a second research site in Poznan, Poland and foreign offices located in Cambridge, MA and San Francisco Bay Area, in the U.S., as well as in Cambridge, UK.
WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. WuXi AppTec’s open-access platform is enabling more than 4,100 collaborators from over 30 countries to improve the health of those in need – and to realize our vision that “every drug can be made and every disease can be treated”.
×Schrödinger is a leading provider of advanced molecular simulations and enterprise software solutions that accelerate and increase the efficiency of drug discovery and materials design. Founded in 1990, Schrödinger has nearly 400 employees and operations across the world. For more information, please visit www.schrodinger.com.
×ChemPass develops and utilizes software and technology for the pharmaceutical industry including a rule-based AI technology for multi-step in silico forward-synthesis that can be utilized for the design of novel synthetically feasible scaffolds and, lead analogs, or for various other general or targeted design tasks. The user friendly SynSpace software (and API) has been available for medicinal and computational chemists, while ChemPass provides lead optimization service using its automated design and ranking platform.
×Select which delegates you would like to meet in a series of prearranged twenty-minute one-to-one meetings. Receive advanced delegate list from which to choose whom you’d like to meet with. Global Engage will schedule these meetings and send you an itinerary before the event
Host your own half or full day pre or post event workshop to a dedicated audience around a subject of your choice. Global Engage will assist with the marketing of your workshop to provide a guaranteed audience.
Market to our event database and / or increase brand awareness by taking a poster position or sponsoring the poster sessions. This can be supplemented by branding options such as placing your logo on the meeting background screen.
Showcase your technologies and products throughout the conference in the dedicated exhibition areas. The booth allows you to provide a pre-recorded video or deliver a live video session to your visitors and capture emails when people register their interest. Live chat with your visitors in discussion groups or 1:1.
Options include:
For further details please contact
Tony Couch/Faizel Ismail
Telephone +44 (0) 1865 849841 or
email [email protected]
Bentham Science Publishers is a major STM journal publisher of 130 plus print and online journal. Out of these, 39 journals have already registered good IMPACT FACTORS as per Journal Citation Reports® 2016. These titles have extensive readership mostly in Europe and North America. For a detailed profile please visit our website at http://www.benthamscience.com. Besides, Bentham Science publishes eBooks in all areas of Science, Technology and Medicine. Our eBooks provide professionals, academicians, corporate researchers, graduates and undergraduates worldwide with the most current information in their subject areas of interest. Our eBooks are also available in the ePub and Kindle formats besides the PDF edition here http://ebooks.benthamscience.com/. Bentham is offering attendees of this conference discounts on its publication. For more information click here
×BioVox is a specialized life sciences news and communication platform keeping you up to date on the rapidly evolving life sciences sector in Belgium and on global scientific and industry trends. BioVox brings exclusive news, in-depth interviews, opinions, and insights on healthcare, agriculture and the bio-based economy.
×Cardea Bio is developing a new generation of (bio)technology infrastructure based on proprietary biology-gated transistors (“Cardean transistors”). Cardean transistors leverage biocompatible graphene instead of silicon and replace optical signal observations with direct electrical molecular signal analysis. Until now, life science data was comprised of static snapshot datasets. With Cardean transistors, the company and its Innovation Partners can generate streaming multi-omics data to measure real-time biological signals. Cardea is now manufacturing chips at scale and partners have started to significantly expand the amount, type and quality of biological data they capture by building products that Conduct Biology™.
×FarmavitaR+ is the professional network of experts and service providers. Network is gathering local consultants from 90 countries in Europe, Asia, North America, Latin America, Australia and Africa. Management of international, multi-centre projects is our core competence.
FarmavitaR+ is providing solutions related to pharmaceutical, medical device, food supplement and cosmetic products. Scope of services is related to solutions for product development, quality assurance, clinical trials, product registration, portfolio analysis, lifecycle management, vigilance/risk management, pricing/reimbursing, market access and promotional compliance.
FarmavitaR+ is brand name of Farmavita Regulanet Ltd.
×Global Information, Inc. is an information service company holding offices in 6 countries and have sales agency contracts with over 300 research companies around the world. We sell 30,000 market research reports published by these publishers and accept custom-made researches.
×Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets. Insight Pharma Reports are used by leading pharmaceutical, biotech, diagnostic, consulting, and financial companies to keep abreast of the latest advances in pharmaceutical R&D, their potential applications and business impacts, and their current and future position in the marketplace.
×Pharma Journalist is a paramount B2b online magazine platform exhibiting targeted and succinct information concerning the world of Pharmaceutical Industry therefore keeping a tab on the updated and latest updates and trends concerning the field.
×PharmaVOICE magazine provides readers with insightful and thought-provoking commentary about the challenges and trends impacting the life-sciences industry in a multiple-perspective format through articles covering a range of issues from molecule through market. PharmaVOICE’s more than 41,000 BPA-qualified subscribers are also kept abreast of the latest trends and information through additional media resources, including WebLinx Interactive WebSeminars, Podcasts, Videocasts, White Papers, E-Surveys and e-Alerts.
×World Pharma Today is a leading Magazine featuring latest industry developments for the Pharmaceutical C-level executives.
×Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.